Related Experiment Video
Updated: Oct 3, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Clinical Outcomes Following a Change in Gestational Diabetes Mellitus Diagnostic Criteria Due to the COVID-19
Niamh Keating1, Kirsten Carpenter2, Kelsey McCarthy2
1UCD Perinatal Research Centre, National Maternity Hospital, University College Dublin, 4 Dublin, Ireland.
Insights
The COVID-19 pandemic led to fewer gestational diabetes mellitus (GDM) diagnoses, but higher-risk pregnancies were still identified. The glucose tolerance test (GTT) remains the gold standard for GDM diagnosis.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Public Health
Background:
- The COVID-19 pandemic prompted changes in gestational diabetes mellitus (GDM) diagnostic practices in many healthcare centers.
- Altered diagnostic criteria and testing protocols may have impacted GDM detection rates and management.
Purpose of the Study:
- To evaluate the impact of COVID-19 related changes on GDM diagnosis and outcomes.
- To compare GDM detection rates, medication use, and obstetric/fetal outcomes between pre-pandemic and pandemic periods.
Main Methods:
- A case-control study design was employed.
- Antenatal patients from April 1 to June 30 in 2019 and 2020 were analyzed.
- Key metrics included GDM detection rates, medication requirements (insulin, metformin), and birth outcomes.
Main Results:
- GDM diagnosis rates significantly decreased during the COVID-19 period (20% in 2020 vs. 42.2% in 2019).
- There was a notable increase in the need for insulin and metformin at diagnosis and term among diagnosed GDM patients in 2020.
- Despite changes in diagnosis and medication, no significant differences in obstetric or fetal outcomes were observed between the two periods.
Conclusions:
- The study suggests a potential underdiagnosis of GDM during the COVID-19 pandemic, although high-risk pregnancies were likely still identified.
- The glucose tolerance test (GTT) is recommended as the gold-standard for GDM diagnosis, with adaptations for social distancing if necessary.
Background:
Due to COVID-19, many centres adopted a change to the diagnosis of GDM.
Methods:
A case-control study of antenatal patients between 1 April and 30 June in 2019 and 2020 looking at detection rates of GDM, use of medication, obstetric, and fetal outcomes.
Results:
During COVID-19, the rate of positive GDM tests approximately halved (20% (42/210) in 2020 vs. 42.2% (92/218) in 2019, (p < 0.01)) with higher rates of requirement for insulin at diagnosis (21.4% (2020) vs. 2.2% (2019); p < 0.01), and at term (31% (2020) vs. 5.4% (2019); p < 0.01). and metformin at diagnosis (4.8% (2020) vs. 1.1% (2019); p < 0.01), and at term (14.3% (2020) vs. 7.6% (2019) p < 0.01), with no differences in birth outcomes.
Conclusions:
There was likely an underdiagnosis of GDM while women at a higher risk of hyperglycaemia were correctly identified. The GTT should be maintained as the gold-standard test where possible, with provisions made for social distancing during testing if required.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

